Cell Therapy Development (via SCTbio)
Oncology, Rare Diseases
Key Facts
About Fortrea
Fortrea Holdings Inc. is a pure-play, publicly traded CRO spun off from LabCorp in 2023, with a mission to accelerate clinical development through tailored, technology-enabled services. The company has established itself as a leader in pharmacovigilance and is at the forefront of integrating diversity and inclusion strategies into trial design. Its core strategy revolves around agile, scalable service delivery models, strategic collaborations, and its proprietary Fortrea Intelligent Technology™ suite to drive operational efficiency and trial success for biopharma and MedTech clients globally.
View full company profile